Cargando…
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
Chondrosarcoma is the most common bone sarcoma in adults. Conventional chondrosarcoma, the commonest histological subtype, is largely resistant to anthracycline-based chemotherapy. There have been anecdotal reports of durable clinical benefit with antiangiogenic agents in this disease. A retrospecti...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574947/ https://www.ncbi.nlm.nih.gov/pubmed/28852958 http://dx.doi.org/10.1007/s12032-017-1030-2 |